XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Impact of new accounting pronouncements
Impact of new accounting pronouncements
Retained Earnings
Beginning Balance at Dec. 31, 2018 $ 1,772,278 $ 7,175 $ 304,709 $ (740,913) $ 2,188,115 $ 13,192 $ (6,771) $ (6,771)
Beginning balance (shares) at Dec. 31, 2018   99,829,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 73,768       73,663 105    
Other comprehensive income/(loss):                
Translation gain/(loss) (2,972)     (2,852)   (120)    
Defined benefit plan adjustment, net of tax 7,156     7,156        
Derivative financial instruments, net of tax 1,864     1,864        
Other comprehensive income/(loss) 6,048     6,168   (120)    
Dividends (41,534)       (41,534)      
Dividends paid to noncontrolling interests (214)         (214)    
Issuance of stock awards 399   399          
Issuance of stock awards (shares)   340,000            
Shares repurchased (7,395)   (7,395)          
Shares repurchased (shares)   (133,000)            
Stock-based compensation 4,560   4,560          
Ending Balance at Mar. 31, 2019 1,801,139 $ 7,175 302,273 (734,745) 2,213,473 12,963    
Ending balance (shares) at Mar. 31, 2019   100,036,000            
Beginning Balance at Dec. 31, 2018 1,772,278 $ 7,175 304,709 (740,913) 2,188,115 13,192 (6,771) (6,771)
Beginning balance (shares) at Dec. 31, 2018   99,829,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 247,337              
Other comprehensive income/(loss):                
Translation gain/(loss) (27,655)              
Defined benefit plan adjustment, net of tax (7,887)              
Derivative financial instruments, net of tax 1,290              
Other comprehensive income/(loss)       (33,460)        
Ending Balance at Sep. 29, 2019 1,854,313 $ 7,175 308,868 (774,373) 2,300,006 12,637    
Ending balance (shares) at Sep. 29, 2019   100,082,000            
Beginning Balance at Dec. 31, 2018 $ 1,772,278 $ 7,175 304,709 (740,913) 2,188,115 13,192 (6,771) (6,771)
Beginning balance (shares) at Dec. 31, 2018   99,829,000            
Other comprehensive income/(loss):                
Shares repurchased (shares) 0              
Ending Balance at Dec. 31, 2019 $ 1,815,705 [1] $ 7,175 310,778 (816,803) 2,301,532 13,023 (209) (209)
Ending balance (shares) at Dec. 31, 2019 100,198,000 100,198,000            
Beginning Balance at Mar. 31, 2019 $ 1,801,139 $ 7,175 302,273 (734,745) 2,213,473 12,963    
Beginning balance (shares) at Mar. 31, 2019   100,036,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 81,286       81,159 127    
Other comprehensive income/(loss):                
Translation gain/(loss) 9,745     9,573   172    
Defined benefit plan adjustment, net of tax 1,807     1,807        
Derivative financial instruments, net of tax (481)     (481)        
Other comprehensive income/(loss) 11,071     10,899   172    
Dividends (43,353)       (43,353)      
Issuance of stock awards 326   326          
Issuance of stock awards (shares)   58,000            
Shares repurchased (1,155)   (1,155)          
Shares repurchased (shares)   (19,000)            
Stock-based compensation 4,306   4,306          
Ending Balance at Jun. 30, 2019 1,853,620 $ 7,175 305,750 (723,846) 2,251,279 13,262    
Ending balance (shares) at Jun. 30, 2019   100,075,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 92,283       92,064 219    
Other comprehensive income/(loss):                
Translation gain/(loss) (34,428)     (33,584)   (844)    
Defined benefit plan adjustment, net of tax (16,850)     (16,850)        
Derivative financial instruments, net of tax (93)     (93)        
Other comprehensive income/(loss) (51,371)     (50,527)   (844)    
Dividends (43,337)       (43,337)      
Issuance of stock awards 330   330          
Issuance of stock awards (shares)   9,000            
Shares repurchased (147)   (147)          
Shares repurchased (shares)   (2,000)            
Stock-based compensation 2,935   2,935          
Ending Balance at Sep. 29, 2019 1,854,313 $ 7,175 308,868 (774,373) 2,300,006 12,637    
Ending balance (shares) at Sep. 29, 2019   100,082,000            
Beginning Balance at Dec. 31, 2019 $ 1,815,705 [1] $ 7,175 310,778 (816,803) 2,301,532 13,023 (209) (209)
Beginning balance (shares) at Dec. 31, 2019 100,198,000 100,198,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) $ 80,236       80,445 (209)    
Other comprehensive income/(loss):                
Translation gain/(loss) (95,212)     (93,575)   (1,637)    
Defined benefit plan adjustment, net of tax 5,780     5,780        
Derivative financial instruments, net of tax (4,555)     (4,555)        
Other comprehensive income/(loss) (93,987)     (92,350)   (1,637)    
Dividends (43,339)       (43,339)      
Issuance of stock awards 376   376          
Issuance of stock awards (shares)   196,000            
Shares repurchased (3,938)   (3,938)          
Shares repurchased (shares)   (65,000)            
Stock-based compensation 597   597          
Ending Balance at Mar. 29, 2020 1,755,441 $ 7,175 307,813 (909,153) 2,338,429 11,177    
Ending balance (shares) at Mar. 29, 2020   100,329,000            
Beginning Balance at Dec. 31, 2019 $ 1,815,705 [1] $ 7,175 310,778 (816,803) 2,301,532 13,023 $ (209) $ (209)
Beginning balance (shares) at Dec. 31, 2019 100,198,000 100,198,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) $ 218,524              
Other comprehensive income/(loss):                
Translation gain/(loss) (37,701)              
Defined benefit plan adjustment, net of tax 15,476              
Derivative financial instruments, net of tax $ (440)              
Other comprehensive income/(loss)       (20,411)        
Shares repurchased (shares) 0              
Ending Balance at Sep. 27, 2020 $ 1,881,333 $ 7,175 310,912 (837,214) 2,390,272 10,188    
Ending balance (shares) at Sep. 27, 2020 100,416,000 100,416,000            
Beginning Balance at Mar. 29, 2020 $ 1,755,441 $ 7,175 307,813 (909,153) 2,338,429 11,177    
Beginning balance (shares) at Mar. 29, 2020   100,329,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 54,990       55,211 (221)    
Other comprehensive income/(loss):                
Translation gain/(loss) 32,864     33,454   (590)    
Defined benefit plan adjustment, net of tax 4,416     4,416        
Derivative financial instruments, net of tax 1,830     1,830        
Other comprehensive income/(loss) 39,110     39,700   (590)    
Dividends (43,451)       (43,451)      
Issuance of stock awards 287   287          
Issuance of stock awards (shares)   2,000            
Shares repurchased (12)   (12)          
Shares repurchased (shares)   (1,000)            
Stock-based compensation 1,339   1,339          
Ending Balance at Jun. 28, 2020 1,807,704 $ 7,175 309,427 (869,453) 2,350,189 10,366    
Ending balance (shares) at Jun. 28, 2020   100,330,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 83,298       83,449 (151)    
Other comprehensive income/(loss):                
Translation gain/(loss) 24,647     24,674   (27)    
Defined benefit plan adjustment, net of tax 5,280     5,280        
Derivative financial instruments, net of tax 2,285     2,285        
Other comprehensive income/(loss) 32,212     32,239   (27)    
Dividends (43,366)       (43,366)      
Issuance of stock awards 256   256          
Issuance of stock awards (shares)   150,000            
Shares repurchased (3,385)   (3,385)          
Shares repurchased (shares)   (64,000)            
Stock-based compensation 4,614   4,614          
Ending Balance at Sep. 27, 2020 $ 1,881,333 $ 7,175 $ 310,912 $ (837,214) $ 2,390,272 $ 10,188    
Ending balance (shares) at Sep. 27, 2020 100,416,000 100,416,000            
[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.